HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michele Cicala Selected Research

beta-Aminoethyl Isothiourea (AET)

3/2022Association between post-reflux swallow-induced peristaltic wave index and esophageal mucosal integrity in patients with GERD symptoms.
11/2021The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough.
1/2019High-resolution Manometry Findings During Solid Swallows Correlate With Delayed Reflux Clearance and Acid Exposure Time in Non-erosive Reflux Disease Patients.
1/2018Role of Esophageal Motility, Acid Reflux, and of Acid Suppression in Nonobstructive Dysphagia.
1/2014Weak peristalsis with large breaks is associated with higher acid exposure and delayed reflux clearance in the supine position in GERD patients.
11/2012Impedance baseline and reflux perception in responder and non-responder non-erosive reflux disease patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michele Cicala Research Topics

Disease

23Gastroesophageal Reflux (GERD)
06/2022 - 03/2002
6Inflammation (Inflammations)
01/2017 - 06/2007
5Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2022 - 10/2007
5Heartburn (Pyrosis)
03/2022 - 03/2002
5Hypersensitivity (Allergy)
03/2022 - 10/2013
5Esophagitis
11/2021 - 09/2011
5Non-Erosive Reflux Disease
01/2020 - 07/2012
4Crohn Disease (Crohn's Disease)
05/2022 - 10/2007
3Ulcerative Colitis
05/2022 - 10/2007
3Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
11/2019 - 01/2018
2Dysbiosis
01/2021 - 02/2016
2Carcinogenesis
10/2013 - 09/2011
2Esophageal Diseases
10/2013 - 09/2011
2Gallstones (Gallstone)
08/2013 - 06/2007
2Barrett Esophagus (Barrett's Esophagus)
09/2011 - 05/2006
1Dyspepsia (Indigestion)
06/2022
1Aerophagy (Swallowing, Air)
06/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
05/2022
1Psoriatic Arthritis
05/2022
1Cough
11/2021
1Chronic Cough
11/2021
1Hiatal Hernia
11/2021
1Diverticular Diseases
01/2021
1Malnutrition (Nutritional Deficiencies)
01/2020
1Sarcopenia
01/2020
1Necrosis
01/2020
1Obesity
12/2019
1Overweight
12/2019
1Fibrosis (Cirrhosis)
01/2018
1Hepatitis
01/2018
1Deglutition Disorders (Dysphagia)
01/2018
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2018
1Chest Pain (Chest Pains)
10/2016
1Eosinophilic Esophagitis
02/2016
1Neoplasms (Cancer)
01/2014
1Pain (Aches)
10/2013
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
10/2013
1Gallbladder Diseases (Gall Bladder Disease)
08/2013
1Abdominal Obesity
09/2011
1Fistula
01/2009

Drug/Important Bio-Agent (IBA)

14AcidsIBA
11/2021 - 03/2005
13Proton Pump InhibitorsIBA
06/2022 - 03/2002
6beta-Aminoethyl Isothiourea (AET)IBA
03/2022 - 11/2012
5Infliximab (Remicade)FDA Link
05/2022 - 10/2007
4CytokinesIBA
10/2013 - 09/2011
3ChemokinesIBA
10/2013 - 09/2011
2Adalimumab (Humira)FDA Link
05/2022 - 09/2013
2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2017
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 01/2009
2Volatile Fatty AcidsIBA
05/2018 - 01/2018
2InulinFDA Link
01/2017 - 01/2014
2Biomarkers (Surrogate Marker)IBA
02/2016 - 06/2007
2Pepsin A (Pepsin)IBA
10/2013 - 09/2011
2Ursodeoxycholic Acid (Urso)FDA LinkGeneric
08/2013 - 06/2007
2CholesterolIBA
08/2013 - 06/2007
2Bile Acids and Salts (Bile Acids)IBA
08/2013 - 09/2011
2Platelet Activating FactorIBA
09/2011 - 06/2007
1Azathioprine (Imuran)FDA LinkGeneric
05/2022
1apremilastIBA
05/2022
1golimumabFDA Link
05/2022
1vedolizumabIBA
05/2022
1ixekizumabIBA
05/2022
1secukinumabIBA
05/2022
1brodalumabIBA
05/2022
1Etanercept (Enbrel)FDA Link
05/2022
1Ustekinumab (CNTO 1275)FDA Link
05/2022
1Leflunomide (Arava)FDA LinkGeneric
05/2022
1guselkumabIBA
05/2022
1FumaratesIBA
05/2022
1Hydroxyurea (Hydrea)FDA LinkGeneric
05/2022
1Methotrexate (Mexate)FDA LinkGeneric
05/2022
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
05/2022
1Sulfasalazine (Azulfidine)FDA LinkGeneric
05/2022
1Thioguanine (Tioguanine)FDA Link
05/2022
1Tacrolimus (Prograf)FDA LinkGeneric
05/2022
1Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2022
1AcitretinFDA Link
05/2022
1Interleukin-12 (IL 12)IBA
05/2022
1Interleukin-17 (Interleukin 17)IBA
05/2022
1Rifaximin (L 105)FDA Link
01/2021
1Capsules (Microcapsules)IBA
01/2020
161-26IBA
01/2020
1Biological ProductsIBA
12/2019
116S Ribosomal RNAIBA
11/2019
1Insulin (Novolin)FDA Link
01/2018
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2018
1Growth Hormone (Somatotropin)IBA
01/2018
1Pharmaceutical PreparationsIBA
01/2018
1Krebs-Ringer solutionIBA
01/2014
1Neurotransmitter Agents (Neurotransmitter)IBA
10/2013
1Interleukin-6 (Interleukin 6)IBA
10/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2013
1Adenosine Triphosphate (ATP)IBA
10/2013
1pyrimidineIBA
10/2013
1purineIBA
10/2013
1Chemotactic FactorsIBA
09/2012
1TRPV Cation ChannelsIBA
09/2011
1AdipokinesIBA
09/2011

Therapy/Procedure

16Therapeutics
06/2022 - 03/2002
1Complementary Therapies (Alternative Medicine)
10/2013